Text Size

Diabetic Patients With End-Stage Renal Disease

This study has been completed.
Sponsor:
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00435786
First received: February 14, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

In diabetic patients with end-stage renal disease to investigate the prevalence of diabetic complications and quality of life and to compare with non-diabetic patients with ESRD and diabetic patients with normal kidney function.


Condition
Diabetes
End-Stage Renal Disease
Cardiovascular Diseases

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective

Resource links provided by NLM:

MedlinePlus related topics: Kidney Failure
U.S. FDA Resources

Further study details as provided by Rigshospitalet, Denmark:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Presence of diabetes and treatment with either dialysis or renal transplantation

Exclusion Criteria:

  • Age < 18
  • Pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00435786

Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Vibeke R Sørensen, MD Department of Nephrology, Rigshospitalet
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00435786     History of Changes
Other Study ID Numbers: J.nr. 01 199/02
Study First Received: February 14, 2007
Last Updated: February 14, 2007
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Cardiovascular Diseases
Kidney Diseases
Kidney Failure, Chronic
 Urologic Diseases
Renal Insufficiency, Chronic
Renal Insufficiency

ClinicalTrials.gov processed this record on May 23, 2013